Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

PET facilitates correct diagnosis&therapy for primary central nervous system lymphoma at unusual locations

Wenqiang Che and Deling Li
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1423;
Wenqiang Che
2Capital Medical University, Beijing Tiantan Hospit Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deling Li
1Beijing Tiantan Hospital Beijing City China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 59 no. supplement 1 1423

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 23, 2018.

Copyright & Usage 
© 2018

Author Information

  1. Wenqiang Che2 and
  2. Deling Li1
  1. 1Beijing Tiantan Hospital Beijing City China
  2. 2Capital Medical University, Beijing Tiantan Hospit Beijing China

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2018 to April 2025

AbstractFullPdf
May 2018600
Jun 20182700
Jul 20181300
Aug 20181100
Sep 20182300
Oct 20182500
Nov 20181200
Dec 20181700
Jan 2019500
Feb 2019800
Mar 2019100
Apr 2019500
May 2019800
Jun 2019700
Jul 2019300
Aug 2019600
Sep 2019100
Oct 2019100
Nov 2019600
Dec 2019100
Jan 2020200
Feb 2020700
Mar 20201800
Apr 20201200
May 2020400
Jun 2020200
Jul 2020400
Aug 20201500
Sep 20202000
Oct 20201600
Nov 20201700
Dec 20201300
Jan 2021200
Feb 2021700
Mar 2021600
Apr 20211200
May 2021900
Jun 2021100
Jul 20211600
Aug 20212700
Sep 2021900
Oct 2021900
Nov 20216000
Dec 20213500
Jan 20226200
Feb 20221900
Mar 20221200
Apr 20221300
May 20222500
Jun 2022400
Jul 2022100
Aug 2022200
Sep 2022500
Oct 2022800
Dec 2022300
Jan 20231000
Feb 2023100
Mar 2023700
Apr 2023100
May 2023300
Jun 2023400
Jul 2023400
Aug 2023200
Sep 2023100
Oct 2023400
Nov 2023300
Dec 2023100
Jan 2024400
Feb 2024200
Mar 2024300
Apr 2024300
May 2024400
Jul 2024200
Aug 2024300
Sep 2024200
Oct 2024500
Nov 2024400
Dec 2024100
Feb 2025300
Mar 2025200
Apr 2025300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PET facilitates correct diagnosis&therapy for primary central nervous system lymphoma at unusual locations
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PET facilitates correct diagnosis&therapy for primary central nervous system lymphoma at unusual locations
Wenqiang Che, Deling Li
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1423;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PET facilitates correct diagnosis&therapy for primary central nervous system lymphoma at unusual locations
Wenqiang Che, Deling Li
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1423;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Transcriptomic signature and pro-osteoclastic secreted factors of abnormal bone marrow stromal cells in fibrous dysplasia
  • Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax
Show more Oncology, Clinical Diagnosis Track

Leukemia/Lymphoma/Myeloma Poster Session

  • PET-CT A valuable tool for detection and follow up of subcutaneous involvement of extranodal marginal zone lymphoma
  • SUVmax cut-off between aggressive and indolent non-Hodgkin lymphoma in non-time of flight FDG PET/CT and time of flight FDG PET/CT
  • Prognostic value of pre-transplant 18-FDG PET/CT in Diffuse Large B Cell Lymphoma after R-DHAC salvage therapy
Show more Leukemia/Lymphoma/Myeloma Poster Session

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire